You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Moodys
Dow
McKinsey
Johnson and Johnson

Last Updated: April 1, 2020

DrugPatentWatch Database Preview

Sulfacetamide sodium - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for sulfacetamide sodium and what is the scope of freedom to operate?

Sulfacetamide sodium is the generic ingredient in seventeen branded drugs marketed by Valeant Pharms North, Fougera Pharms, Perrigo Co Tennessee, Taro, Allergan, Alcon, Schering, Pharmafair, Miza Pharms Usa, Akorn, Sola Barnes Hind, Novartis, Optopics, Alcon Pharms Ltd, Bausch And Lomb, and Sandoz Inc, and is included in thirty NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for sulfacetamide sodium. Fifteen suppliers are listed for this compound.

Recent Clinical Trials for sulfacetamide sodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sidney Kimmel Cancer Center at Thomas Jefferson UniversityN/A

See all sulfacetamide sodium clinical trials

Pharmacology for sulfacetamide sodium
Medical Subject Heading (MeSH) Categories for sulfacetamide sodium
Synonyms for sulfacetamide sodium
127-56-0
30760ZE777
AB00513796
AC-7629
Acetamide, N-((4-aminophenyl)sulfonyl)-, monosodium salt
Acetamide, N-((4-aminophenyl)sulfonyl)-, sodium salt (1:1)
Acetamide, N-[(4-aminophenyl)sulfonyl]-, monosodium salt
Acetamide, N-[(4-aminophenyl)sulfonyl]-, sodium salt (1:1)
ACETAMIDE, N-SULFANILYL-, MONOSODIUM SALT
Acetamide, N-sulfanilyl-, N-sodium deriv
Acetamide, N-sulfanilyl-, sodium deriv
AK00726227
AKOS003281404
AKOS025402286
Albucid soluble
Albucid-Natrium
Albucide
Almocetamide
Antebor
API0004257
AS-13361
BDBM50248189
Beocid-isoptal
Blefamide
Bleph 10
BLEPH-30
C08051
C8H9N2NaO3S
CHEBI:9327
CHEMBL1200416
DB-041863
DTXSID40889336
EINECS 204-848-4
Farmamid
FT-0631741
Galseptil
H994
HMS3652G10
Isopto cetamide
J-005502
KS-0000129C
Locula
MFCD00149555
Minims sulphacetamide
N-(4-Aminophenylsulfonyl)acetamide sodium salt
N-[(4-aminophenyl)sulfonyl]acetamide, sodium salt
N-Acetyl-4-aminobenzenesulfonamide Sodium Salt
N-Acetylsulfanilamide Sodium Salt
N-Sulfanilylacetamide sodium
N-Sulfanilylacetamide, sodium salt
N(1)-acetylsulfanilamide sodium
N(1)-acetylsulfanilamide sodium salt
N(sup 1)-Acetylsulfanilamide sodium
N(sup 1)-Acetylsulfanilamide sodium salt
N1-Acetylsulfanilamide sodium salt
Oc-U-Mid
Octsetan
Ocusulf-10
OCUSULF-30
Opulets sulpjacetamide
PQMSFAORUFMASU-UHFFFAOYSA-M
Prontamid
Q27108353
S0578
s4081
SCHEMBL3051698
Sebizon lotion
Sodium acetyl((4-aminophenyl)sulfonyl)amide
sodium acetyl(4-aminophenylsulfonyl)amide
sodium acetyl[(4-aminophenyl)sulfonyl]azanide
Sodium albucid
Sodium N-sulfanilylacetamide
Sodium sulamyd
Sodium sulfacetamide
Sodium sulfacyl
Sodium sulfanilylacetamide
Sodium, N(sup 1)-acetylsulfanilamido-
sodium;acetyl-(4-aminophenyl)sulfonylazanide
Soluble sulfacetamide
Soluble sulfacyl
ST50407307
Sulamyd sodium
Sulf 10
Sulf-10 Ophthalmic
Sulf-15
Sulfableph
Sulfacetamid natrium
Sulfacetamide sodium anhydrous
Sulfacetamide sodium salt
Sulfacetamide Sodium, Pharmaceutical Secondary Standard; Certified Reference Material
sulfacetamide-sodium
Sulfacetamide, sodium
Sulfacetamide, sodium salt
SulfacetamideSodiumSaltHydrate
Sulfacetamidum natricum
Sulfacyl sodium
Sulfacyl sodium salt
Sulfacyl sol
Sulfacyl soluble
Sulfacylum
Sulfair 10
Sulfair Forte
Sulfair-15
Sulphacetamide sodium
Sulten-10
SW196656-2
UNII-30760ZE777

US Patents and Regulatory Information for sulfacetamide sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sola Barnes Hind SODIUM SULFACETAMIDE sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 084146-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Miza Pharms Usa OCUSULF-30 sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 080660-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Allergan BLEPH-10 sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 080028-001 Approved Prior to Jan 1, 1982 AT RX No Yes   Start Trial   Start Trial   Start Trial
Sola Barnes Hind SODIUM SULFACETAMIDE sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 084145-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmafair SULFAIR 10 sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 087949-001 Dec 13, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Moodys
Dow
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.